Quantcast

Posts related to ‘SGP’

Merck & Schering-Plough Face Cholesterol Firing Squad (MRK, SGP)

Posted: March 31, 2008 at 7:45 am

Usually drug companies look forward to presenting data on their drugs and medical treatments.  The the American College of Cardiology meeting was this weekend, and the findings and recommendations are ...
Read Full Story »

Top 10 Pre-Market Analyst Calls (GFIG, GU, HTZ, MBT, NSM, PM, SGP, TOC, TIBX, VOD)

Posted: March 31, 2008 at 6:18 am

These are not all of the calls we are seeing this morning, but these are the top analyst calls we see affecting shares in pre-market trading this Monday morning:GFI Group ...
Read Full Story »

Media Digest 3/31/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

Posted: March 31, 2008 at 2:50 am

According to Reuters, the Treasury Department will announce a proposed major overhaul of the US financial regulatory system.Reuters writes that Yahoo! (YHOO) introduced Shine, a site for women. Reuters writes ...
Read Full Story »

Top 10 Pre-Market Analyst Calls (CPLA, CEPH, DYN, HBC, MS, SGP, SLM, TASR, TROW, VISN)

Posted: February 13, 2008 at 7:34 am

Below are the top analyst calls that 247WallSt.com is looking at this morning:Capella Education (NASDAQ: CPLA) started as Neutral at JPMorgan.Cephalon (NASDAQ: CEPH) raised to Strong Buy at Broadpoint.Dynegy (NYSE: ...
Read Full Story »

Schering-Plough Relief on Partner Earnings (SGP)

Posted: January 30, 2008 at 8:18 am

Schering-Plough Corp. (NYSE: SGP) is probably breathing a sigh of relief this morning after Merck's earnings as it is partners with the drug giant on Vytorin and Zetia for cholesterol ...
Read Full Story »

Media Digest 1/28/2008 Reuters, WSJ, NYTimes, FT, Barron’s

Posted: January 28, 2008 at 4:14 am

According to Reuters, gaps in controls at Societe Generale allowed a junior trader to make at $73 billion losing bet on European shares prices.Reuters writes that Countrywide's (CFC) CEO will ...
Read Full Story »

NY State Investigates Merck (MRK) And Schering-Plough (SGP)

Posted: January 27, 2008 at 7:34 am

Once Eliot Spitzer left his office as prosecutor to become governor of New York State many feared that there would be no one left to devil large corporations and Wall ...
Read Full Story »

Top 10 Pre-Market Analyst Calls (GTOP, HAS, MAT, ITRI, MVL, RIMM, RAD, SGP)

Posted: December 21, 2007 at 8:36 am

If analysts were cowboys they'd say, "It's getting pretty darn thin out there on the research front."  Here are the few analyst calls we are looking at today ahead of ...
Read Full Story »

Top 10 Pre-Market Analyst Calls (AET, RATE, CELG, DE, FNM, FRE, GRP, ISIL, PHG, SGP, TDW)

Posted: November 26, 2007 at 7:45 am

Aetna (AET) raised to Overweight at JPMorgan.Bankrate (RATE) raised to Outperform at Bear Stearns.Celgene (CELG) raised to Buy at Banc of America.Deere (DE) raised to Buy at Banc of America.Fannie ...
Read Full Story »

Biotech Implosion: Novacea (NOVC, SGP)

Posted: November 5, 2007 at 8:29 am

Novacea, Inc. (NASDAQ:NOVC) has ended its Phase III ASCENT-2 clinical trial of Asentar(TM) (DN-101).  Unfortunately this is Novacea's lead investigational cancer therapy for the treatment of patients with androgen-independent prostate ...
Read Full Story »

Mixed Short Interest in Drug & Medical Stocks (June 2007)

Posted: June 24, 2007 at 12:16 pm

As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a bit of a mixed bag.  GlaxoSmithkline (GSK) saw the lagest ...
Read Full Story »

Cramer’s Picks & Pans in Pharmaceuticals

Posted: June 12, 2007 at 5:53 pm

Stock Tickers: MRK, PFE, JNJ, GSK, SGP, LLY, WYE, NVS, NVOOn tonight's MAD MONEY on CNBC, Jim Cramer said he keeps getting asked about Big Pharma drug stocks.  He'd rather ...
Read Full Story »

Biotechs & Pharmas Bracing For ASCO Annual Meeting

Posted: May 30, 2007 at 6:30 pm

This weekend we have the mother of all future cancer treatment conferences: ASCO, or The American Society of Clinical Oncology.  Cancer stocks in the last few weeks have been seeing ...
Read Full Story »

Novacea and Schering-Plough Prostate Cancer Pact; Remind You of Anyone?

Posted: May 30, 2007 at 9:23 am

Novacea (NOVC-NASDAQ) is seeing its shares up more than 70% after signing a pact with Schering-Plough (SGP-NYSE) over the development and commercialization of Asentar for the treatment of prostate cancer.  ...
Read Full Story »

Short Selling Up in Drug & Medical Stocks

Posted: May 22, 2007 at 4:36 pm

Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw an increased activity in short selling in May versus April.  ...
Read Full Story »